SCHEMBL4460920

SCHEMBL4460920

O=C(OCC=S(=O)=O)ON1C(=O)CCC1=O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1111161 0.79 CYP3A4 (0.37)
SCHEMBL14063664 0.76 MGLL (0.33) MGLL
SCHEMBL8035936 0.74 MGLL (0.32) MGLL
SCHEMBL17447 0.73 MGLL (0.37) MGLL
SCHEMBL4756591 0.73 MGLL (0.31) MGLL
SCHEMBL5395199 0.73 MGLL (0.34) MGLL
SCHEMBL1799869 0.73 ALDH1A1 (0.46)
SCHEMBL6130582 0.72 CYP3A4 (0.34)
SCHEMBL1949595 0.72 ALOX12 (0.38) MGLL
SCHEMBL13057087 0.72 ADORA3 (0.33) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578450-A4 AMPLIFICATION OF BIOTIN-MEDIATED TARGETING ACCESS PHARMACEUTICALS AUSTRAL (AU) 2009-06-17 EP claimed
EP-1578450-A1 AMPLIFICATION OF BIOTIN-MEDIATED TARGETING Access Pharmaceuticals Australia Pty Ltd (AU) 2005-09-28 EP claimed
WO-2004045647-A1 AMPLIFICATION OF BIOTIN-MEDIATED TARGETING ACCESS PHARMACEUTICALS AUSTRALIA PTY LTD (AU) 2004-06-03 WO claimed
EP-0701448-B1 AMPLIFICATION OF THE VITAMIN B 12 UPTAKE SYSTEM USING POLYMERS BIOTECH AUSTRALIA PTY LTD (AU) 2002-08-14 EP claimed